| 标题 |
Abstract GS2-05: First-line ribociclib vs placebo with goserelin and tamoxifen or a non-steroidal aromatase inhibitor in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: Results from the randomized phase III MONALEESA-7 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:D Tripathy; J Sohn; S-A Im; M Colleoni; F Franke; et al 出版日期:2018-02-16 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)